Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey

Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aime...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:BMC public health Ročník 10; číslo 1; s. 237
Hlavní autori: Kotronen, Anna, Yki-Järvinen, Hannele, Männistö, Satu, Saarikoski, Liisa, Korpi-Hyövälti, Eeva, Oksa, Heikki, Saltevo, Juha, Saaristo, Timo, Sundvall, Jouko, Tuomilehto, Jaakko, Peltonen, Markku
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: London BioMed Central 10.05.2010
BioMed Central Ltd
Springer Nature B.V
BMC
Predmet:
Adult
Biostatistics
Blood & organ donations
Clinical medicine
Comorbidity
Confidence intervals
Diabetes
Diabetes Mellitus, Type 2 - epidemiology
Diagnosis
Disease
Environmental Health
Enzyme kinetics
Epidemiology
Ethanol
Fatty liver
Fatty Liver - epidemiology
Fatty Liver - metabolism
Fatty Liver, Alcoholic - epidemiology
Female
Finland
Glucose Intolerance - epidemiology
Glucose tolerance tests
Health surveys
Hospitals
Humans
India - epidemiology
Insulin resistance
Internal medicine
Liver
Liver diseases
Male
Medicine
Medicine & Public Health
Mens health
Metabolic disorders
Metabolic Syndrome - epidemiology
Methods
Middle Aged
Mortality
Population studies
Prevalence
Public Health
Research Article
Spectrum analysis
Surveys
Type 2 diabetes
Vaccine
Womens health
Finland
Oral Glucose Tolerance Test
Abnormal Glucose Tolerance
Proton Magnetic Resonance Spectroscopy
High Alcohol Consumption
Metabolic Syndrome
ISSN:1471-2458, 1471-2458
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:Background Non-alcoholic fatty liver disease (NAFLD) is known to be associated with the metabolic syndrome (MetS) and abnormal glucose tolerance. Whether alcoholic fatty liver disease (AFLD) is associated with similar metabolic abnormalities has not been examined in a population-based study. We aimed at assessing the prevalences of NAFLD and AFLD, and to examine to what extent these conditions are associated with MetS and abnormal glucose tolerance. Methods The cohort included 2766 Finnish subjects (45-74 years) from the population-based FIN-D2D survey. Features of insulin resistance, components of the MetS, glucose tolerance status by oral glucose tolerance test, serum liver enzyme concentrations, and daily alcohol consumption were assessed. Results Subjects with NAFLD and AFLD were equally obese and had similar fasting and insulin concentrations. The prevalences of NAFLD and AFLD were 21% (95% CI: 19%-22%) and 7% (95% CI: 6%-8%). The MetS was slightly more prevalent in AFLD (73%) than in NAFLD (70%, p = 0.028), and type 2 diabetes was similarly prevalent in NAFLD and AFLD (24-25%). The MetS and type 2 diabetes were more prevalent in subjects with NAFLD or AFLD compared to subjects with normal LFTs (53% and 14%, p < 0.0001 for both). Discussion and conclusion In Finnish middle-aged population, the prevalence of NAFLD is 3-fold higher than that of AFLD. The prevalences of MetS and type 2 diabetes are, however, significantly increased in both NAFLD and AFLD compared to subjects with normal LFTs. Subjects with AFLD are thus similarly metabolically unhealthy as subjects with NAFLD.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1471-2458
1471-2458
DOI:10.1186/1471-2458-10-237